Skip to search formSkip to main contentSkip to account menu

CD22 Expressing Cell Count

Known as: B-Cell Receptor CD22 Expressing Cell Count, CD22 
The determination of the amount of CD22 expressing cells per unit present in a sample.
National Institutes of Health

Related topics

Related topics

6 relations
CD22 antigenCD22 geneCD22 protein, humanCDISC SDTM Laboratory Test Terminology by Code

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
[Analysis of cell morphology and immunophenotypic characteristics in 47 cases of multiple myeloma].
OBJECTIVE This study was to investigate the cell morphology and cell immune phenotypic characteristics in patients with multiple… 
2015
2015
MicroRNA-19a and CD22 Comprise a Feedback Loop for B Cell Response in Sepsis
Background MicroRNA-19a (miR-19a), an oncogenic microRNA, has been recently reported to target CD22 in B cell lymphoma cell lines… 
2013
2013
Abstract 4744: CD22-targeting epratuzumab mediates trogocytosis of multiple cell-surface markers on normal, malignant, and lupus B cells.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background. Epratuzumab, a humanized anti-CD22… 
2012
2012
CD22-Targeting Epratuzumab Down-Regulates Multiple BCR Regulators On the Surface of Normal, Lupus, and Malignant B Cells
Abstract 1357 Background. The humanized anti-CD22 antibody, epratuzumab, has demonstrated therapeutic activity in clinical trials… 
2012
2012
A Phase I Study of DCDT2980S, an Antibody-Drug Conjugate (ADC) Targeting CD22, in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Abstract 59 Introduction: CD22 is a lineage marker expressed in most B-cell lymphomas. DCDT2980S is an ADC consisting of an anti… 
Review
2003
Review
2003
Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma?
CONTEXT B-lineage acute lymphoblastic leukemia (ALL) with a mature phenotype and L1 morphology is a rare condition that may pose… 
2002
2002
Difference in CD22 molecules in human B cells and basophils.
1994
1994
Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with b‐cell malignancies
Background. Studies on radiolabeled monoclonal antibodies (MoAb) have dealt mainly with single antibodies. However, major… 
Highly Cited
1988
Highly Cited
1988
Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomas
Ricin A chain‐containing immunotoxins (IT‐As) specific for the human B‐cell antigen, CD22, were prepared from 4 monoclonal… 
1987
1987
Correlation of monoclonal antibody phenotyping and cellular DNA content in non‐Hodgkin's lymphoma. The southeastern cancer study group experience
Flow cytometric measurements of DNA ploidy and synthetic (S) fractions are quantitative parameters that can aid in the diagnosis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)